Many Organizations Launch Their Precision Medicine Initiatives With Pharmacogenomics. Why?

0 %

90% Of Patients Have A Genetic Variation Affecting Drug Response1

0 %

18% Of 4 Billion Prescriptions In The US Affected By Actionable Pharmacogenomics2

0 %

34% of adverse drug reactions caused by Drug-Gene interactions (rather than Drug-Drug interactions)3

Reducing Costs Of Care

The impact on safety and quality is unquestionable. And leveraging PGx data at the point of care reduces costs – impacting success with ACOs and other shared savings programs.

Harmonized PGx Data

How does 2bPrecise help clinicians make better medication decisions? An intuitive dashboard delivers critical information about patients’ ability to metabolize current medications – and triggers alerts about potentially devastating adverse reactions. And once the PGx test has been performed, the data can be re-interrogated and applied to clinical decision making throughout the patients’ lifetime.

Better Decisions, Better Results

Point of Care Results

Test results at the point of care allow providers to discuss current medications with patients in real time.

Lifetime Consistency

PGx test results remain consistent throughout the patient’s lifetime. A single test, done now, can be used by doctors as they make decisions for years into the future.

Request A


We enable healthcare organizations to get started with precision medicine anywhere they want – oncology? pediatrics? cardiology? pharmacogenomics?

Schedule Your Demo Today